Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

NCT01186419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Transfusional Iron Overload
Beta-thalassemia

Interventions

DRUG: SPD602 (FBS0701, SSP-004184)

Sponsor

Shire